Search

Find out what’s contributing to a marked increase in the death rate for liver cancer.

… Monday, October 15, 2018 Summary Liver cancer death rates have risen sharply in recent years, in part due to an increase in chronic conditions that cause damage to the liver. Meanwhile, recent advances in liver cancer treatment have improved the outlook for people with the disease. Liver cancer death

An epigenetic mechanism may make small cell lung cancer vulnerable to a new kind of attack.

… Monday, February 13, 2017 Summary Small cell lung cancer (SCLC) is notoriously difficult to treat because it quickly acquires resistance to chemotherapy. Scientists at Memorial Sloan Kettering have uncovered a molecular mechanism by which SCLC cells develop resistance, opening the door to new treatments

Learn how to manage menopause symptoms if you have breast cancer

… Friday, October 28, 2016 Summary The menopause symptoms that can sometimes happen as a result of breast cancer treatment are an unwelcome side effect. Memorial Sloan Kettering medical oncologist Shari Goldfarb shares her recommendations for how women can find relief. Highlights Women with breast cancer

Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.

… Monday, August 3, 2020 Summary A large international study led by researchers at Memorial Sloan Kettering has immediate clinical relevance for risk assessment and treatment of people with myelodysplastic syndrome and acute myeloid leukemia. Considered the “guardian of the genome,” TP53 is the most commonly

An uptick in colorectal cancer in people under the age of 50 is an alarming trend that led Memorial Sloan Kettering to develop the first of its kind Center for Young Onset Colorectal Cancer in 2018. Read more.

… Monday, August 31, 2020 VIDEO | 01:05 Learn More about MSK's Center for Young Onset Colorectal Cancer Gastroenterologist Robin Mendelsohn explains how young people with colorectal cancer are treated at MSK. She also discusses ongoing research into the causes of young onset colorectal cancer. Video Details

LOXO-195, a next-generation TRK inhibitor also known as BAY 2731954, has shown signs of clinical activity in individuals with NTRK gene fusion-positive solid tumors that have become resistant to first-generation TRK inhibitors. Results from a phase I clinical trial and a US Food and Drug Administration expanded access program were presented by David Hyman, MD, the Chief of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center (MSK), at the American Association for Cancer Research (AACR) Annual Meeting 2019. This research is featured in the meeting’s press program, and findings are being presented in the “Next Generation of Clinical Trials in Molecularly Driven Therapy” minisymposium.

… Monday, April 1, 2019 LOXO-195, a next-generation TRK inhibitor also known as BAY 2731954, has shown signs of clinical activity in individuals with NTRK gene fusion-positive solid tumors that have become resistant to first-generation TRK inhibitors. Results from a phase I clinical trial and a US Food

Sixth-year graduate student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper accepted for publication in the January 28, 2012 issue of Science.

… Wednesday, August 15, 2012 Sixth-year student Alexandria Miller was awarded the Chairman’s Prize for her first-author paper “Crystal Structure of the Human Two-Pore Domain Potassium Channel K2P1,” published in the journal Science on January 26, 2012 . The study, which revealed the three-dimensional shape

Memorial Sloan Kettering Cancer Center today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center.

… Friday, March 14, 2025 Memorial Sloan Kettering Cancer Center (MSK) today announced that its state-of-the-art cancer care pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. The new building has been thoughtfully designed to meet

Why endometrial cancer is especially dangerous for Black women.

… Monday, June 10, 2024 The numbers are stark and deeply troubling. Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than 66,000

Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months.

… Monday, December 14, 2020 Patients with profound immunosuppression after undergoing hematopoietic stem-cell transplantation or receiving chimeric antigen receptor (CAR) T cell therapy may shed viable SARS-CoV-2 for at least two months, according to a retrospective study of 18 cancer patients treated